What is the current market size?

The Nuclear Medicine Equipment market size reached USD 1.2 billion in 2023, driven by aging populations and rising chronic disease prevalence.

What is the forecasted growth rate?

The future outlook predicts a CAGR of 5.5% from 2026 to 2033, led by advancements in radiopharmaceuticals and diagnostic imaging demand.

What are the key growth drivers?

Key drivers include increasing cancer incidence, adoption of hybrid imaging systems, and growth of nuclear cardiology applications.

What challenges hinder market expansion?

High equipment costs, stringent regulatory compliance, and limited reimbursement policies pose significant challenges to market growth.

Which regions are leading the market?

North America dominates with 40% market share, followed by Europe, due to advanced healthcare infrastructure and R&D investments.

Who are the top market players?

Leading companies include Siemens Healthineers, GE Healthcare, and Philips, known for innovative PET/CT and SPECT systems.

What are emerging opportunities?

Emerging opportunities lie in Asia-Pacific’s expanding healthcare access, AI integration, and precision medicine applications.

How is technology shaping the future?

AI-driven image analysis and next-gen radiotracers are enhancing diagnostic accuracy, while compact systems improve accessibility.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA mandate rigorous safety trials, influencing product approvals and standardization globally.

What Is the Global Nuclear Medicine Equipment Market Worth in 2026?

Nuclear Medicine Equipment by Application (Hospitals, Imaging Centers, Academic & Research Institutes), by Types (Hybrid SPECT, Standalone SPECT), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Nuclear Medicine Equipment Market Size | CAGR 6.8 Forecast 2033

What Is the Global Nuclear Medicine Equipment Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Nuclear Medicine Equipment Market Overview

The Nuclear Medicine Equipment market encompasses diagnostic and therapeutic technologies such as PET and SPECT scanners, radiopharmaceuticals, and related imaging systems. This market is critical for precision medicine, enabling early disease detection and targeted cancer therapies. Nuclear Medicine Equipment market size is projected to expand significantly through 2033, driven by advancements in molecular imaging, rising demand for non-invasive diagnostics, and increasing prevalence of chronic diseases. The growth outlook remains robust, with macroeconomic factors and healthcare digitization fueling industry expansion.

Loading chart…

The 2026 Nuclear Medicine Equipment market is valued at $5.3 billion, reflecting a CAGR of 6.2% over 2026–2033. Key drivers include AI-integrated imaging for enhanced diagnostics, regulatory approvals for novel radiotracers, and growing geriatric populations. North America dominates the market due to advanced healthcare infrastructure, while Asia-Pacific emerges as the fastest-growing region, propelled by rising healthcare investments. Competitive dynamics are intensifying as manufacturers prioritize R&D for hybrid imaging systems and cost-effective radiopharmaceuticals.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.03 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Philips; Siemens; Digirad; Mediso Medical Imaging Systems; Toshiba; Bozlu; Neusoft; Compañía Mexicana; SurgicEye; CMR Naviscan; DDD-Diagnostic; Positron; TeraRecon; GE Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Aging populations and rising chronic disease prevalence are fueling demand for Nuclear Medicine Equipment market diagnostics, particularly in oncology and cardiology, where early detection is critical. This demographic shift is expected to amplify the Nuclear Medicine Equipment market size through 2030.

Advancements in hybrid imaging technologies, such as PET-MRI and SPECT-CT, are enhancing diagnostic precision and expanding treatment applications, thereby driving adoption in both developed and emerging markets.

Restraints2 items

High capital costs and maintenance expenses for nuclear imaging systems remain a barrier to adoption, particularly in low- and middle-income countries with limited healthcare budgets.

Stringent regulatory requirements for radiopharmaceuticals and equipment approvals are slowing product commercialization and increasing time-to-market, dampening investor enthusiasm.

Opportunities2 items

Expansion of personalized medicine and molecular imaging is creating new growth avenues, as nuclear medicine plays a pivotal role in targeted therapies and biomarker development.

Growing healthcare infrastructure investments in Asia-Pacific are unlocking untapped demand, with countries like India and China adopting advanced imaging solutions to meet rising patient volumes.

Challenges2 items

Supply chain vulnerabilities for radiopharmaceuticals, such as reliance on a few cyclotron facilities for isotope production, risk disrupting equipment performance and patient care.

Reimbursement limitations in key markets are constraining profitability for providers, leading to delayed equipment upgrades and reduced ROI for manufacturers.

Market Segmentation

Loading chart…

The application segment of the Nuclear Medicine Equipment market is divided into diagnostic imaging, therapeutic applications, and research. Diagnostic imaging dominates, driven by rising demand for early disease detection, particularly in oncology and cardiology, with Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) accounting for over 60% of revenue. Therapeutic applications, including radiopharmaceutical therapies for cancer and neurodegenerative diseases, are growing at a CAGR of 7.5%, supported by advancements in targeted alpha therapy. Research applications, though smaller in market share, fuel innovation in preclinical and clinical trials. This Nuclear Medicine Equipment segmentation highlights how diagnostic needs anchor the market, while therapeutic expansion and research R&D create growth vectors.

The types segment includes gamma cameras, PET scanners, and therapeutic devices. Gamma cameras, used for SPECT imaging, remain the largest category due to their cost-effectiveness and widespread adoption in hospitals. PET scanners, integrating molecular imaging for cancer diagnostics, are projected to grow at 6.8% CAGR, driven by hybrid systems like PET-CT. Therapeutic devices, such as brachytherapy equipment and radiopharmaceutical delivery systems, cater to oncology and nuclear cardiology, with rising demand for minimally invasive treatments. Subtypes like compact PET scanners and AI-enhanced gamma cameras reflect technological differentiation. This market taxonomy underscores how equipment types evolve to meet precision medicine requirements while balancing accessibility and advanced capabilities.

Nuclear Medicine Equipment Segmentation Breakdown7 items

Application

Hospitals

Imaging Centers

Academic & Research Institutes

Types

Hybrid SPECT

Standalone SPECT

Regional Insights

Loading chart…

The Nuclear Medicine Equipment market growth is dominated by North America, which holds a 40% value share, driven by advanced healthcare infrastructure, high adoption of precision diagnostics, and strong regulatory frameworks. Strategic investments in AI-integrated radiopharmaceuticals and government funding for cancer research further solidify its leadership. Meanwhile, Asia Pacific emerges as the fastest-growing region, with a 20% value, fueled by rising disposable incomes, expanding healthcare access in emerging economies, and partnerships between global manufacturers and local hospitals. The Europe market (30%) benefits from mature ecosystems, favorable reimbursement policies, and aging populations prioritizing early disease detection. Latin America (5%) and the Middle East & Africa (5%) show potential through infrastructure modernization and public-private collaborations, though constrained by resource gaps.

Regional Drivers for Nuclear Medicine Equipment Market Expansion5 items

North America: Policy mandates for diagnostic accuracy, R&D investments in PET/MRI hybrid systems

Europe: Demographic shifts (aging populations) and cross-border R&D alliances

Asia Pacific: Urbanization-driven healthcare demand and cost-effective equipment adoption

Latin America: Public health reforms and telemedicine integration for rural diagnostics

Middle East & Africa: Strategic investments in nuclear medicine training and infrastructure upgrades

Competitive Landscape

The global Nuclear Medicine Equipment market is moderately consolidated, with a mix of established multinational corporations and niche regional players. The Nuclear Medicine Equipment competitive landscape is shaped by product innovation, regulatory approvals, and strategic partnerships to navigate fragmented distribution channels. Key players leverage certifications (e.g., ISO, CE) and differentiated technology (e.g., PET/CT hybrid systems) to command premium pricing, while cost-conscious end-users prioritize cost-per-procedure economics. Pricing pressures from payor reimbursement models coexist with demand for AI-integrated imaging solutions, creating tension between differentiation and commoditization.

Competitive strategies emphasize R&D investment for next-gen isotopes and software algorithms, alongside geographic expansion to emerging markets. However, compliance costs for radiation safety standards and supply chain volatility for rare isotopes constrain profit margins. Players differentiate through hybrid service models (e.g., as-a-service offerings), proprietary workflows, and localized after-sales support. Vertical integration of radiopharmaceutical production is gaining traction to mitigate supply risks, though this requires significant capital outlay.

Companies Strategy Snapshot6 items

Philips — innovation pipeline in hybrid imaging systems

Siemens — strategic partnerships for AI-driven diagnostics

GE Healthcare — vertical integration of radiopharmaceuticals

Mediso — OEM tie-ups for compact PET systems

Neusoft — regional expansion in Asia-Pacific markets

Bozlu — cost-optimized manufacturing for emerging economies

Market Ecosystem

The Nuclear Medicine Equipment ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream end users. Value creation begins with specialized materials and software development, flows through equipment design and integration, and culminates in diagnostic and therapeutic applications across healthcare facilities. Regulatory compliance and clinical validation serve as critical enablers of value capture throughout the chain.

Raw material/component suppliers — supply isotopes, detectors, and shielding materials for equipment production

OEMs/Manufacturers — design and produce nuclear imaging systems (e.g., PET/CT, SPECT scanners)

Technology providers — develop proprietary software for image processing and dose management

System integrators — configure and deploy customized solutions for hospital workflows

Distributors/Channel partners — manage regional equipment delivery and initial training

Service providers/After-sales — offer maintenance contracts and technical support

Regulators/Standards bodies — enforce safety protocols and certification requirements

Control points reside with regulators, who gatekeep product approvals, and OEMs, whose proprietary technologies create switching costs for end users. Supply chain constraints for rare isotopes and hardware components introduce dependency risks. Interoperability with hospital IT systems often requires coordinated partnerships between integrators and software providers, shaping adoption dynamics across the ecosystem.

Recent Industry Insights

The Nuclear Medicine Equipment industry trends over the past 18 months reflect a dynamic shift driven by technological innovation and strategic alliances. Key players such as Siemens Healthineers and GE HealthCare have prioritized partnerships with AI-focused firms like Google Health and NVIDIA to enhance imaging precision and diagnostic speed in PET/SPECT systems. Mergers & acquisitions have also accelerated, with Cardinal Health acquiring a niche radiopharmaceutical distributor in 2023 to expand its supply chain capabilities. Product/technology launches highlight the industry’s pivot toward AI-integrated solutions, including Siemens’ new digital PET/CT platform and a FDA-cleared AI-powered quantitative SPECT system by GE. Regulatory bodies, notably the FDA, have streamlined approvals for advanced radiopharmaceuticals, boosting adoption of personalized cancer therapies. Meanwhile, enterprise trends reveal a growing demand for compact, cost-effective nuclear imaging systems in emerging markets, spurred by remote healthcare infrastructure projects. Funding rounds reached record levels in 2024, with startups like Curium Photonics securing $120M to develop next-gen gamma camera technology, signaling strong investor confidence in the sector’s growth trajectory.

Analyst Overview

The Nuclear Medicine Equipment market outlook remains robust, driven by aging populations, rising cancer incidence, and advancements in diagnostic accuracy. Market attractiveness is underscored by strong demand for PET/CT and SPECT/CT systems, supported by government funding and healthcare digitization trends. However, high capital costs and regulatory hurdles present entry barriers.

Key Insights5 items

Competitive intensity is moderate, with established players like Siemens Healthineers, GE Healthcare, and Philips dominating, while niche innovators target emerging markets.

Long-term growth is projected at a CAGR of 5-6%, fueled by expanding applications in oncology and cardiology, alongside AI-integrated imaging solutions.

Innovation focuses on compact, cost-effective systems and AI-driven diagnostics, though adoption lags in low-income regions due to infrastructure gaps.

Demand-supply imbalances persist, particularly for radiopharmaceuticals, due to limited production facilities and strict regulatory oversight.

Key risks include geopolitical trade tensions, reimbursement policy shifts, and technological obsolescence in legacy systems.

Strategic investments in R&D and partnerships will be critical to address unmet needs, while sustainable manufacturing and training programs can mitigate supply-side constraints.

12 items

1. Executive Summary

2. Nuclear Medicine Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nuclear Medicine Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Nuclear Medicine Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Nuclear Medicine Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Nuclear Medicine Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Nuclear Medicine Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Nuclear Medicine Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Nuclear Medicine Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Nuclear Medicine Equipment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Nuclear Medicine Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Nuclear Medicine Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nuclear Medicine Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nuclear Medicine Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Nuclear Medicine Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Nuclear Medicine Equipment Market Competition by Key Manufacturers

9.1. Global Nuclear Medicine Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Nuclear Medicine Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Philips

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Siemens

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Digirad

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Mediso Medical Imaging Systems

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Toshiba

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Bozlu

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Neusoft

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Compañía Mexicana

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. SurgicEye

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. CMR Naviscan

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. DDD-Diagnostic

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Positron

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. TeraRecon

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. GE Healthcare

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nuclear Medicine Equipment Market

Figure 4: Global Nuclear Medicine Equipment Market: Drivers

Figure 5: Global Nuclear Medicine Equipment Market: Challenges

Figure 6: Global Nuclear Medicine Equipment Market: Trends

Figure 7: Global Nuclear Medicine Equipment Market: Opportunity

Figure 8: Global Nuclear Medicine Equipment Market: Restraint

Figure 9: Global Nuclear Medicine Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Nuclear Medicine Equipment Market Value (USD Million) By Region

Figure 19: Global Nuclear Medicine Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Nuclear Medicine Equipment Market Value (USD Million) By Region

Figure 27: Global Nuclear Medicine Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Nuclear Medicine Equipment Market Volume (K) By Region

Figure 29: Global Nuclear Medicine Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Nuclear Medicine Equipment Market Value (USD Million) By Region

Figure 37: Global Nuclear Medicine Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Nuclear Medicine Equipment Market Volume (K) By Region

Figure 39: Global Nuclear Medicine Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Nuclear Medicine Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nuclear Medicine Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nuclear Medicine Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Nuclear Medicine Equipment Market Value (USD Million) By Region

Table 14: Global Nuclear Medicine Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Nuclear Medicine Equipment Market Volume (K) By Region

Table 31: Global Nuclear Medicine Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Nuclear Medicine Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Nuclear Medicine Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Nuclear Medicine Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Philips Basic Information And Sales Area

Table 52: Philips. Products Portfolio

Table 53: Siemens Basic Information And Sales Area

Table 54: Siemens. Products Portfolio

Table 55: Digirad Basic Information And Sales Area

Table 56: Digirad. Products Portfolio

Table 57: Mediso Medical Imaging Systems Basic Information And Sales Area

Table 58: Mediso Medical Imaging Systems. Products Portfolio

Table 59: Toshiba Basic Information And Sales Area

Table 60: Toshiba. Products Portfolio

Table 61: Bozlu Basic Information And Sales Area

Table 62: Bozlu. Products Portfolio

Table 63: Neusoft Basic Information And Sales Area

Table 64: Neusoft. Products Portfolio

Table 65: Compañía Mexicana Basic Information And Sales Area

Table 66: Compañía Mexicana. Products Portfolio

Table 67: SurgicEye Basic Information And Sales Area

Table 68: SurgicEye. Products Portfolio

Table 69: CMR Naviscan Basic Information And Sales Area

Table 70: CMR Naviscan. Products Portfolio

Table 71: DDD-Diagnostic Basic Information And Sales Area

Table 72: DDD-Diagnostic. Products Portfolio

Table 73: Positron Basic Information And Sales Area

Table 74: Positron. Products Portfolio

Table 75: TeraRecon Basic Information And Sales Area

Table 76: TeraRecon. Products Portfolio

Table 77: GE Healthcare Basic Information And Sales Area

Table 78: GE Healthcare. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Nuclear Medicine Equipment Market Value (USD Million) By Region

Table 88: Global Nuclear Medicine Equipment Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Nuclear Medicine Equipment Market Volume (K) By Region

Table 105: Global Nuclear Medicine Equipment Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Nuclear Medicine Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.03 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Philips; Siemens; Digirad; Mediso Medical Imaging Systems; Toshiba; Bozlu; Neusoft; Compañía Mexicana; SurgicEye; CMR Naviscan; DDD-Diagnostic; Positron; TeraRecon; GE Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options